Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

20 septembre 2017

08:00
CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire/ -- AOBiome, a clinical-stage life sciences company advancing patented microbiome-targeted therapies for systemic and local inflammatory conditions, today announced that the United States Patent and...

08:00
AMSTERDAM, September 20, 2017 /PRNewswire/ -- Norgine B.V. today announced the launch of LYMPHOSEEK® (technetium Tc 99m tilmanocept) in Italy. LYMPHOSEEK® is a radiopharmaceutical used for diagnostic purposes by nuclear medicine specialists and...

08:00
NEWARK, Calif., Sept. 20, 2017 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced preliminary results from the Phase 1 study of PTG-300 in normal healthy volunteers. PTG-300 is an injectable hepcidin mimetic peptide,...

07:24
SAN FRANCISCO, Sept. 20, 2017 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that new data across its wholly-owned immuno-oncology (I-O) portfolio will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) Annual...

07:00
SAN FRANCISCO, Sept. 20, 2017 /PRNewswire-USNewswire/ -- The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) today announced the first patients have begun treatment in a new pancreatic cancer multi-center clinical...

06:49
EDINBURGH, Scotland, September 20, 2017 /PRNewswire/ -- Edinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has commenced a pivotal Phase IIb clinical trial with...

06:04
MADRID, September 20, 2017 /PRNewswire/ -- Désireux de trouver une solution aux besoins insatisfaits des patients souffrant de différents types de cancer, PharmaMar (MCE: PHM) annonce le début d'une étude clinique de Phase I avec PM14, un nouveau...

06:00
PRINCETON, N.J., Sept. 20, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...

03:30
MADRID, September 20, 2017 /PRNewswire/ -- With the motivation of finding a solution to the unmet needs of patients with different types of cancer, PharmaMar (MCE: PHM) announces the start of a Phase I clinical study with PM14, a new antitumor...


19 septembre 2017

16:30
ISNES, Belgium, Sept. 19, 2017 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced its colorectal cancer (CRC) strategy for Europe.  As part of its strategy, Volition plans to select a frontline panel to be validated...

11:00
OXFORD, England, September 19, 2017 /PRNewswire/ -- UK Prime Minister Theresa May Announces UK facility with Capacity to Generate One Billion Friendlytm Aedes Mosquito Eggs per Week Oxitec Ltd, a wholly owned subsidiary of Intrexon Corporation...

10:30
CINCINNATI, Sept. 19, 2017 /PRNewswire-USNewswire/ -- When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital...

10:24
MARIETTA, Ga., Sept. 19, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected...

10:20
IRVINE, Calif., Sept. 19, 2017 /PRNewswire/ -- AIVITA Biomedical today announced the discovery of a new method for capturing and using intercellular signaling molecules to induce the reactivation of stem cell niches. The implication of this discovery...

10:00
EXTON, Pa., Sept. 19, 2017 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it will present preclinical data on its investigational antibody-drug conjugate (ADC) MORAb-202 at the 8th Annual World ADC being held...

09:53
Ce mécanisme d'action novateur promeut une innocuité et une efficacité accrues pour le traitement des AVC et des infarctus du myocarde CAMBRIDGE, Massachusetts, 19 septembre 2017 /PRNewswire/ -- Thrombolytic Science, LLC (TSI), société de stade...

09:46
SEATTLE, 19 septembre 2017 /PRNewswire/ -- La septicémie est la principale source de décès par infection au monde, avec plus de 18 millions de cas par an et constitue l'infection la plus coûteuse traitée dans les hôpitaux des États-Unis, atteignant...

09:36
ROSEMONT, Ill., Sept. 19, 2017 /PRNewswire-USNewswire/ -- Osteoarthritis (OA) is a progressive "wear and tear" disease of the joint. Osteoarthritis of the knee (knee OA) may not be totally preventable but according to Elizabeth Matzkin, MD, an...

09:24
DALLAS and MARLBOROUGH, Mass., Sept. 19, 2017 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study evaluating the performance of the...

09:15
BALTIMORE, Sept. 19, 2017 /PRNewswire/ -- AgeneBio, a pharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, today announced it has been awarded a grant from the National Institute on Aging (NIA)...

09:00
PHILADELPHIA, Sept. 19, 2017 /PRNewswire-USNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) and Northwell Health's Cohen Children's Medical Center have been approved for a $8.5 million funding award by the Patient-Centered...

09:00
NEW YORK, Sept. 19, 2017 /PRNewswire/ -- Petra Pharma, a drug development company focused on novel enzyme targets, and Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods,...

09:00
YOKNEAM, Israel, September 19, 2017 /PRNewswire/ -- Today, Rapid Medical, a company focused on the development of neurovascular interventional devices, announced that the first patient was enrolled to the TIGERTRIEVR registry at the Cantonal...

09:00
SAN CARLOS, Calif., Sept. 19, 2017 /PRNewswire/ -- Imago BioSciences, a clinical-stage pharmaceutical company developing novel therapies for hematological and inflammatory diseases, announced today that the first patients have been dosed in a Phase...

08:40
CARVER, Mass., Sept. 19, 2017 /PRNewswire/ -- A thorough review of dozens of studies led scientists to conclude that healthcare professionals should be telling their patients to have cranberry products as a first step in reducing recurrent UTIs. The...

08:15
ARLINGTON, Va., Sept. 19, 2017 /PRNewswire/ -- The Global Coalition Against Cervical Cancer (GC3) applauds the recent release of draft cervical cancer screening recommendations by the United States Preventive Services Task Force (USPSTF). GC3...

08:05
HONOLULU, Sept. 19, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) welcomes the findings of a clinical study recently published in the New England Journal of Medicine that validate the crucial role inflammation plays in cardiovascular health. The...

08:02
WELLESLEY, Mass., Sept. 19, 2017 /PRNewswire/ -- 4G Clinical announced its recognition today as a finalist in the 2017 Scrip Awards for its RTSM solution, Prancer. Shortlisted in the 'Best Technological Development in Clinical Trials ?...

08:00
New Clinical Evidence Guided by Artificial Intelligence that Could Significantly Enhance Prostate Cancer Detection and Reduce Over-Diagnosis and Unnecessary Treatments in Benign Prostate Hyperplasia Patients arises from Research Collaboration with...

07:30
Clinical trials evaluating PMN310 expected to initiate in 2019 TSX: PMN TORONTO and CAMBRIDGE, MA, Sept. 19, 2017 /CNW/ - ProMIS Neurosciences, Inc., a company focused on discovery and development of precision treatments for neurodegenerative...

07:03
SEATTLE, Sept. 19, 2017 /PRNewswire/ -- Sepsis is the primary cause of death from infection worldwide, with over 18 million cases per year, and represents the most costly condition treated within hospitals in the United States, hitting 20 billion...

07:00
LANDING, New Jersey, September 19, 2017 /PRNewswire/ -- A new clinical study investigated the mechanism of BCM-95®, a high-potency turmeric extract in treating pancreatic cancer. The study revealed evidence that indicates BCM-95 could help overcome...

06:30
Sustained safety observed over 48 weeks of treatment Beneficial clinical effects in liver sustained over 48 weeks of treatment Positive results support requests for meetings with both FDA and EMA to define the clinical-regulatory pathway for...

06:30
Maintien du profil d'innocuité sur une période de 48 semaines de traitement Effets cliniques bénéfiques pour le foie maintenus sur une période de traitement de 48 semaines Les résultats positifs supportent les demandes pour des rencontres avec la...

06:30
BOTHELL, Wash., Sept. 19, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife"),...

05:24
HAMBURG, Germany and PITTSBURG, September 19, 2017 /PRNewswire/ -- Indivumed GmbH (Indivumed) and Helomics® Corporation (Helomics) announce their intentions to collaborate to analyze human cancer biospecimens and annotated clinical data from...

04:33
YOKNEAM, Israel, September 19, 2017 /PRNewswire/ -- - The post marketing registry will assess the real-life safety and performance of the TIGERTRIEVER revascularization device Today, Rapid Medical, a company focused on the development of...

04:33
YOKNEAM, Israël, September 19, 2017 /PRNewswire/ -- - Le registre post-commercialisation évaluera l'innocuité et les performances dans la vie réelle du dispositif de revascularisation TIGERTRIEVER Aujourd'hui, Rapid Medical, une entreprise axée sur...

04:00
EXTON, Pa., Sept. 19, 2017 /PRNewswire/ ? Four months post-launch, keeping pace with neurologists' previous projections, Genentech's Ocrevus continues to display impressive growth in both user base and brand share. Although only 42% of surveyed...

01:00
LAUSANNE, Switzerland, September 19, 2017 /PRNewswire/ -- After starting the commercialisation of AneVivo, its first assisted reproductive technology device, Anecova is proud to announce a major breakthrough this summer: the birth of the 6 first...


18 septembre 2017

20:30
LONDON, Sept. 18, 2017 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone...

14:11
- La Dr Marisa López-Teijón, directrice de ce centre de renommée internationale en procréation assistée, a été décerné le Prix Ig Nobel de Médecine - Les prix, qui ont lieu à l'Université Harvard, reconnaissent les recherches scientifiques les plus...

12:48
PROVIDENCE, Rhode Island, 18 sept. 2017 /PRNewswire/ -- EpiVax, Inc. (« EpiVax »), pionnier dans les domaines de la bioinformatique et de l'ingénierie immunitaire, a annoncé aujourd'hui une nouvelle collaboration financée par les Instituts américains...

12:31
CAMBRIDGE, Mass., Sept. 18, 2017 /PRNewswire/ -- Thrombolytic Science, LLC (TSI), a clinical stage vascular health and biotechnology company, today announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving therapy...

11:35
NESS ZIONA, Israel, September 18, 2017 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, announced...

11:29
NORTH CHICAGO, Ill., Sept. 18, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced that the Phase 3 MURANO study of VENCLEXTAtm/VENCLYXTOtm (Venetoclax) Tablets in combination...

11:21
- Dr Marisa López-Teijón, directrice du centre de procréation médicalement assistée de renommée internationale, a reçu le prix Ig-Nobel de médecine - La cérémonie de remise de prix, qui s'est déroulée à l'université Harvard, honore les recherches...

11:00
NEW YORK, Sept. 18, 2017 /PRNewswire-USNewswire/ -- Brain structures that control sexual and aggressive behavior in mice are wired differently in females than in males. This is the finding of a study led by scientists at NYU School of Medicine and...

10:50
SAN DIEGO, September 18, 2017 /PRNewswire/ -- The ADC community will join together for World ADC San Diego this week (September 20-22, Sheraton San Diego Marina). This annual summit, now in its 8th year is expected to draw record attendance of over...

10:49
PROVIDENCE, R.I., Sept. 18, 2017 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") a pioneer in the fields of bioinformatics and immune engineering, today announced a new NIH-funded collaboration to develop a protective avian influenza A (H7N9) vaccine....

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18